Magnetic resonance angiography devices are expected to lead the angiography devices market at 20.0% share in 2026, followed by coronary angiography as forecast to hold 37.2% share of procedure in 2026. Adoption depends on recurring equipment replacement and specification standardization, with certification effort and supplier-switching costs forming principal barriers.